Last Close
33.39 $
Jul 7, 26
Market Cap
160.5 M $
Q1 2026 (TTM)
52-Week Range
%+59.0
%193.1
0.79
1.38
%-6.5
-%80.9
1M
+13.3%
3M
+491.4%
6M
+203.2%
YTD
+264.4%
1Y
+59.0%
3Y
-72.5%
Returns are computed from split-adjusted closes; dividends are not included.
Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
CUE last closed at 33.39 $ (Jul 7, 26). Price data is refreshed after every trading day.
Cue Biopharma (CUE) has a market capitalization of approximately 160.5 M $ as of the latest reported period.
Key peers of Cue Biopharma include RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S., Mesoblast Ltd, TELIX Pharmaceuticals Ltd. A detailed metric comparison is available on the Peers tab.
Data on this page refreshes once per day. Price data as of Jul 7, 26. This content is for informational purposes only and is not investment advice.